|
| | 2-amino-9-((1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one hydrate Basic information | | Uses |
| Product Name: | 2-amino-9-((1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one hydrate | | Synonyms: | 2-amino-9-((1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one hydrate;(1R,3R,4S);Entecavir (1R,3R,4S) Diastereomer;2-amino-9-((1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2- methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one;Entecavir impurity A -F;2-amino-9-((1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1H-purin-6(9H)-one;Entecavir EP Impurity A;Cave Impurity B | | CAS: | 1367369-78-5 | | MF: | C12H15N5O3 | | MW: | 277.28 | | EINECS: | | | Product Categories: | | | Mol File: | 1367369-78-5.mol |  |
| | 2-amino-9-((1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one hydrate Chemical Properties |
| Boiling point | 661.4±65.0 °C(Predicted) | | density | 1.81±0.1 g/cm3(Predicted) | | pka | 14.22±0.60(Predicted) |
| | 2-amino-9-((1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one hydrate Usage And Synthesis |
| Uses | Entecavir EP Impurity A is an epimeric impurity of the antiviral drug Entecavir. | | Uses | An epimeric impurity of the antiviral drug Entecavir (E558900). |
| | 2-amino-9-((1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one hydrate Preparation Products And Raw materials |
|